Overview
Photosensitive occipital lobe epilepsy is a rare form of epilepsy in which seizures originate from the occipital lobe of the brain and are triggered by visual stimuli such as flickering lights, patterns, or transitions between light and dark environments. This condition primarily affects the visual processing areas of the brain and is classified under reflex epilepsies. It typically begins in childhood or adolescence and is characterized by an abnormal photoparoxysmal response on electroencephalography (EEG) when exposed to intermittent photic stimulation. The hallmark symptoms include visual phenomena such as elementary visual hallucinations (colored circles, spots, or flashing lights), transient blindness or visual field deficits, eye pain, and forced eye deviation during seizures. These visual symptoms may remain localized to the occipital region or may spread to involve other brain areas, potentially leading to secondary generalized tonic-clonic seizures. Some patients also experience headache following seizures, which can sometimes lead to misdiagnosis as migraine with aura. Nausea and vomiting may accompany seizure episodes. Management of photosensitive occipital lobe epilepsy involves both lifestyle modifications and pharmacological treatment. Patients are advised to avoid known visual triggers, including flickering screens, strobe lights, and certain visual patterns. Wearing polarized or blue-tinted lenses may help reduce photosensitivity. Antiseizure medications such as valproate and levetiracetam are commonly used and are often effective in controlling seizures. The prognosis is generally favorable, with many patients achieving good seizure control, and some individuals may experience remission over time, particularly those with onset in childhood.
Also known as:
Multifactorial
Caused by a mix of several genes and environmental factors
Childhood
Begins in childhood, roughly ages 1 to 12
FDA & Trial Timeline
10 eventsPulnovo Medical, Inc. — NA
Dartmouth-Hitchcock Medical Center — NA
University Hospital, Toulouse — NA
Subha Subramanian — NA
Far Eastern Memorial Hospital
The First Affiliated Hospital of Guangzhou Medical University — NA
University of Santiago de Compostela — NA
The First Affiliated Hospital of Guangzhou Medical University — NA
Jie Zhong — NA
The First Affiliated Hospital of Guangzhou Medical University — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Photosensitive occipital lobe epilepsy.
7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Photosensitive occipital lobe epilepsy.
Community
No community posts yet. Be the first to share your experience with Photosensitive occipital lobe epilepsy.
Start the conversation →Latest news about Photosensitive occipital lobe epilepsy
Disease timeline:
New recruiting trial: The Role of POLE Mutation in High Risk Endometrial Cancer.
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: Flexible Ureteroscopy With a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for 1-2 cm Lower Pole Kidney Stones
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: Pole Walking Intervention in Retirement Communities
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: The Effect of Different Body Positions and Channel Sheaths on RIRS
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
New recruiting trial: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
A new clinical trial is recruiting patients for Photosensitive occipital lobe epilepsy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Photosensitive occipital lobe epilepsy
What is Photosensitive occipital lobe epilepsy?
Photosensitive occipital lobe epilepsy is a rare form of epilepsy in which seizures originate from the occipital lobe of the brain and are triggered by visual stimuli such as flickering lights, patterns, or transitions between light and dark environments. This condition primarily affects the visual processing areas of the brain and is classified under reflex epilepsies. It typically begins in childhood or adolescence and is characterized by an abnormal photoparoxysmal response on electroencephalography (EEG) when exposed to intermittent photic stimulation. The hallmark symptoms include visual
How is Photosensitive occipital lobe epilepsy inherited?
Photosensitive occipital lobe epilepsy follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Photosensitive occipital lobe epilepsy typically begin?
Typical onset of Photosensitive occipital lobe epilepsy is childhood. Age of onset can vary across affected individuals.
Are there clinical trials for Photosensitive occipital lobe epilepsy?
Yes — 7 recruiting clinical trials are currently listed for Photosensitive occipital lobe epilepsy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Photosensitive occipital lobe epilepsy?
12 specialists and care centers treating Photosensitive occipital lobe epilepsy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.